Happy to be part of this publication on ‘Hemolytic Uremic Syndrome’

Happy to be part of this publication on ‘Hemolytic Uremic Syndrome’ with colleagues from Saudi Arabia and Dr Christopher Licht from Canada, which deals with how and when to discontinue Eculizumab (a very costly therapy indeed) in selected group of patients.